Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Atossa Therapeutics Inc
(NQ:
ATOS
)
1.780
-0.050 (-2.74%)
Streaming Delayed Price
Updated: 2:45 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,476,713
Open
1.850
Bid (Size)
1.770 (7)
Ask (Size)
1.780 (1)
Prev. Close
1.830
Today's Range
1.760 - 1.910
52wk Range
0.5901 - 1.940
Shares Outstanding
125,785,200
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Via
InvestorPlace
This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm"
October 24, 2023
Dr. Steven Quay MD, PhD, President & CEO of Atossa Therapeutics Inc. (NASDAQ: ATOS) was recently interviewed by Benzinga.
Via
Benzinga
Performance
YTD
+90.36%
+90.36%
1 Month
+81.60%
+81.60%
3 Month
+97.24%
+97.24%
6 Month
+131.76%
+131.76%
1 Year
+159.88%
+159.88%
More News
Read More
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 18, 2023
Via
ACCESSWIRE
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 08, 2023
Via
Benzinga
Atossa Therapeutics backing Endoxifen in the fight against breast cancer
August 23, 2023
Via
News Direct
Recap: Atossa Therapeutics Q2 Earnings
August 08, 2022
Via
Benzinga
Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst
September 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
September 08, 2023
Via
Benzinga
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 09, 2023
Via
Benzinga
50% Of Women Have Elevated Breast Density, Which Significantly Decreases the Effectiveness of Mammography - Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
July 12, 2023
Via
ACCESSWIRE
50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
July 11, 2023
Via
Benzinga
3 Penny Stocks to Make Your ‘Get Rich’ Dreams Come True
July 06, 2023
Via
InvestorPlace
3 Penny Stocks Set to Pass the $5 Mark Soon
June 23, 2023
Via
InvestorPlace
3 Penny Stocks That Could Skyrocket in the Next 12 Months
June 07, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 24, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 17, 2023
Via
InvestorPlace
7 High-Potential Penny Stocks in the Biotech Sector
May 04, 2023
Via
InvestorPlace
3 Best Penny Stocks Under $1 to Buy in April
April 11, 2023
Via
InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for April
April 04, 2023
Via
InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
Via
Benzinga
Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket
August 08, 2022
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
June 08, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.